In addition, this work revealed the potential of S. albus to produce many others secondary metabolites normally obtained from plants, including compounds of medical relevance as dihydro-β-agarofuran and of interest in perfume industry as β-patchoulene, suggesting that it might be an alternative model for their industrial production. In S. lividans, actinorhodins production was strongly activated in the recombinant strains whereas undecylprodigiosins were significantly reduced. Activation of cryptic metabolites in Streptomyces species might represent an alternative approach for pharmaceutical drug discovery.
Introduction
Species of the Streptomyces genus are the main producers in nature of antibiotics and other bioactive secondary metabolites of great medical and industrial significance. genomics has recently revealed that the biosynthetic potential of these bacteria has been largely underestimated. Streptomyces genomes contain a great reservoir of secondary metabolite biosynthetic gene clusters, most of which are silent under standard laboratory conditions (Baltz 2008) . Cryptic gene clusters encode putative natural products whose production has not been detected. There is a large difference between the number of biosynthetic gene clusters present in sequenced genomes and the number of known produced molecules, since cryptic metabolites outnumber the known produced metabolites by an order of magnitude. Activation of silent gene clusters for antibiotics and other bioactive secondary metabolites is therefore one Abstract Activation and silencing of antibiotic production was achieved in Streptomyces albus J1074 and Streptomyces lividans TK21 after introduction of genes within the thienamycin cluster from S. cattleya. Dramatic phenotypic and metabolic changes, involving activation of multiple silent secondary metabolites and silencing of others normally produced, were found in recombinant strains harbouring the thienamycin cluster in comparison to the parental strains. In S. albus, ultra-performance liquid chromatography purification and nMr structural elucidation revealed the identity of four structurally related activated compounds: the antibiotics paulomycins A, B and the paulomenols A and B. Four volatile compounds whose biosynthesis was switched off were identified by gas chromatography-mass spectrometry analyses and databases comparison as pyrazines; including tetramethylpyrazine, a compound with important clinical applications to our knowledge never reported to be produced by Streptomyces.
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of the most important areas of research for novel drug discovery in Streptomyces.
Different approaches have been reported to successfully activate silent cryptic biosynthetic gene clusters in microorganisms. Most strategies have been recently reviewed (Zhu et al. 2013; Chiang et al. 2011; van Wezel and McDowall 2011) . These include changes in environmental factors, like empirical variation of growth conditions, and co-cultivation with microorganisms from the same ecosystem in an attempt to simulate their natural habitat (Brakhage and Schroeckh 2011; Perez et al. 2011 ). An alternative approach involves overexpression of regulatory genes, either pleiotropic or pathway-specific activator genes, as reported for the awakening of the expression of a silent biosynthetic gene cluster in Aspergillus nidulans (Zerikly and Challis 2009) .
Among antibiotics, the beta-lactam carbapenem thienamycin (Kahan et al. 1979 ) is the most potent, most broadspectrum of all natural antibiotics known so far (Demain 2009). Cloning of the thienamycin biosynthetic gene cluster (thn) from the producer Streptomyces cattleya (núñez et al. 2003 ) has contributed to the knowledge of thienamycin biosynthesis (Freeman et al. 2008; Hamed et al. 2009; Bodner et al. 2010; rodríguez et al. 2011) , and its regulation (rodríguez et al. 2008, 2010) . In the course of unpublished attempts to produce thienamycin in two genetically well characterized Streptomyces strains, Streptomyces albus J1074 and Streptomyces lividans TK21, by transformation with cosmids containing the thn gene cluster, strong pigmentation was induced in both recombinant strains. Comparative metabolite profiling of the recombinant strains with the parental strains performed by ultra-performance liquid chromatography (UPlC) and gas chromatography-mass spectrometry (gC-MS) analysis revealed that, surprisingly instead of the expected thienamycin product, dramatic changes in the metabolome of the recombinant strain were observed. Here we report the successful activation of silent antibiotic biosynthetic pathways and silencing of others normally produced in both Streptomyces hosts after transformation with the thn gene cluster from S. cattleya. Although the mechanism underlying this event has not been identified, our study might represent a promising approach for the discovery of many secondary metabolites, whose gene clusters remain otherwise cryptic in Streptomyces genomes.
Materials and methods

Bacterial strains, culture conditions and cloning vectors
Streptomyces albus J1074 and S. lividans TK21 ATCC 55251 were used in this study. Escherichia coli DH10B (Invitrogen) was used as a cloning host. For antibiotic production cultures were grown on r5A medium (Fernán-dez et al. 1998) . Cosmids cosCAT25, cosCAT14 and cosCAT22 are pKC505 derived low copy number vectors (núñez et al. 2003) containing different regions of the thn and cph-II gene clusters from S. cattleya (Fig. 1) . The cph-II refers to a subcluster of cephamycin genes, physically linked to the thn cluster, wich contains the cphU transcriptional activator (rodríguez et al. 2011) . Cosmid cosCAT32 is a pHZ1358 derived high copy number vector, obtained (l.e. núñez, unpublished data) during the generation of a ΔthnD-cphU deletion mutant (rodríguez et al. 2011) ; it harbours the complete nucleotide sequence under Accession number AJ421798. When needed, antibiotics were added to a final concentration of 25 μg/ml for thiostrepton and apramycin.
DnA manipulations, sequencing and subcloning experiments Plasmid DnA preparations, restriction endonuclease digestions, ligations, protoplasts transformation and other DnA manipulations were performed according to standard procedures for E. coli (Sambrook and russell 2001) and for Streptomyces (Kieser et al. 2000) .
Chromatographic analysis routinely, compounds produced by Streptomyces strains were assessed in cultures on r5A solid medium. Agar plugs of about 7 ml were taken from the plates and extracted with ethyl acetate and 1 % formic acid. The organic fraction was evaporated and the residue redissolved in 100 μl of a mixture of DMSO and methanol (50:50) . These samples were analyzed by reversed phase chromatography in an Acquity UPlC equipment with a BeH C18 column (1.7 μm, 2.1 × 100 mm, Waters), with acetonitrile and 0.1 % trifluoroacetic acid as solvents. Samples were eluted with 10 % acetonitrile during 1 min, followed by a linear gradient from 10 to 100 % in 7 min and an additional isocratic hold with 100 % acetonitrile during 2 min, at a flow rate of 0.5 ml/ min and a column temperature of 35 °C. For HPlC-MS analysis, an Alliance chromatographic system coupled to a ZQ4000 mass spectrometer and a Symmetry C18 (2.1 × 150 mm, waters) was used. Solvents were the same as above and elution was performed with an initial isocratic hold with 10 % acetonitrile during 4 min followed by a linear gradient from 10 to 88 % acetonitrile over 26 min, at 0.25 ml/min. MS analysis were done by electrospray ionization in the positive mode, with a capillary voltage of 3 kV and a cone voltage of 50 V. Detection and spectral characterization of peaks was performed in both cases by photodiode array detection and empower software (Waters).
Isolation of paulomycins
Streptomyces albus/cosCAT25 was cultivated in 3 l of solid r5A medium (approximately 100 plates) at 28 °C during 10 days. Agar cultures were removed from the plates, placed in three 2 liter erlenmeyer flasks, covered with ethyl acetate and 1 % formic acid, and extracted in an orbital shaker for 3 h at 30 °C and 150 rpm. The organic extracts were evaporated in vacuo and the extraction was repeated. The resulting dry extract was redissolved in a mixture of DMSO and methanol and the compounds of interest were purified by preparative HPlC using a SunFire C18 column (10 μm, 10 × 250 mm, Waters). Compounds were chromatographed with mixtures of acetonitrile or methanol and 0.05 % TFA in water in isocratic conditions optimized for each peak, at 7 ml/min. After every purification step, the collected compounds were diluted fourfold with water and were desalted and concentrated by solid-phase extraction, being finally lyophilized. nMr spectroscopic and mass spectrometric analysis nMr spectra were measured on a Varian Vnmr 500 (1H, 500 MHz; 13C, 125 MHz) spectrometer. eSIMS was recorded on a Finnigan lCQ ion trap mass spectrometer. HrMS was recorded by eSIMS on an Agilent lC/MSD TOF (resolution: 10 000; 3 ppm mass accuracy; inlet systems: Agilent Technologies 1200 Series lC pumps) mass spectrometer (manufacturer: Agilent, Palo Alto, CA, USA).
gas chromatography-mass spectrometry (gC-MS) analysis
Qualitative analysis was performed by coupled gC-MS (Chromatograph Agilent 6890n coupled with a 5975B mass spectometer) mainly as described for geosmin detection (gust et al. 2003) . Volatiles released from Streptomyces strains during 2 weeks' growth on r5A plates at 28 °C were absorbed onto 100 mg of activated charcoal (norit gAC 1240) placed in the lid of each petri dish. The charcoal was extracted with 0.5 ml of chloroform (Merck) for an hour, and then filtered through cotton wool. One microliter of each extract was analyzed by gC-MS as follows: capillary column, fused silica (30 m; 0.25-mm inside diameter; 0.25-μm film thickness); carrier gas, He (0.82 kPa on column injection); temperature program: isothermal for 1 min at 40 °C, change from 40 to 210 °C at a rate of 10 °C per min, and isothermal for 25 min at 210 °C; energy of ionization, 70 eV. The identity of these volatile compounds was determined by comparing their mass spectra with the Whiley and nIST (national Institute of Standards and Technology) libraries. 932,876) as has been reported in the recently sequenced S. cattleya genome (Barbe, et al. 2011) . After protoplast transformation of two genetically well characterized host strains, S. albus J1074 and S. lividans TK21, with cosmids (núñez et al. 2003) containing different combinations of thn biosynthetic and regulatory genes ( Fig. 1 ) striking phenotypic changes involving strong pigmentation were noticed in some of the recombinant strains (Fig. 2) . However, S. albus and S. lividans recombinant strains do not produce the expected thienamycin product, even when they harbour the complete cluster carried by cosCAT32, instead dramatic changes in the metabolome were observed.
Results
Phenotypic changes detected in S. albus and S. lividans
When the S. albus strains harbouring the pKC505 derived cosmids cosCAT25 or cosCAT14 were grown on r5A solid medium, changes in the mycelium pigmentation colour involving the appearance of a redish brown pigment were observed. In addition, differences in the odour of sporulated cultures were also detected after olfactory analysis, carried out by smelling solid cultures of these strains. In contrast, no changes were detected in relation to the parental strain in S. albus harbouring cosCAT22, which displayed the same phenotype as the negative controls (S. albus parental strain and S. albus harbouring the pKC505 empty vector). Similar phenotypic and metabolic changes were also detected when we used cosCAT32, derived from the multicopy cosmid vector pHZ1358, containing the entire 32 kb region (Accession number AJ421798) represented in Fig. 1 . In S. lividans no phenotypic changes were detected with the above mentioned cosmids based on the pKC505 monocopy cosmid. In contrast, when we used the multicopy cosCAT32, the appearance of an intense blue pigment was clearly detected.
Activation and silencing of secondary metabolite biosynthetic pathways in S. albus
The striking changes in the phenotypes observed in both heterologous hosts prompted further analysis involving comparative metabolite profiling of the recombinant strains with the parental strains.
ethyl acetate extracts of r5A solid cultures of the above mentioned S. albus strains after 7 days of growth were analysed by UPlC. Although the reddish brown pigment was not extracted with ethyl acetate (or other organic solvents as methanol or acetone), metabolomic profiling of organic extracts from S. albus harbouring cosCAT25 revealed important changes in the peak profile when compared to the control strains, S. albus parental strain and S. albus carrying the pKC505 vector (Fig. 3) . Differences in multiple metabolites were observed when absorbance was measured at different wave lengths (Fig. 3) . These involve activation of at least six silent metabolites and silencing of at least two active metabolites, the corresponding peaks are indicated by arrows in the maxplot. Figure 4 shows changes detected at 323 nm, which involve activation of several silent or poorly expressed secondary metabolites (peaks 1-4) and silencing of another (2.4 min retention time). S. albus harbouring cosCAT14 (Fig. 1 ) displayed a metabolic profile pattern similar to S. albus/cosCAT25, whereas the S. albus/cosCAT22 pattern was similar to the control cultures, S. albus carrying the pKC505 vector and S. albus parental strain (data not shown).
Purification and structural elucidation of compounds 1-4
Four compounds whose production was activated in S. albus/cosCAT25 were purified by preparative HPlC and structurally characterized by nuclear magnetic resonance spectroscopy. The nMr spectroscopic and mass spectrometric analysis (Supporting information) proved identity with the respective four structurally related known compounds: paulomycins A, B and paulomenols A and B (Fig. 5) . Paulomycins A and B are antibiotics with very potent activity against gram-positive bacteria (Staphylococcus aureus, Bacillus cereus and other Streptomyces) initially described in S. paulus (Argoudelis et al. 1982) and later in S. albus J1074 (Majer and Chater 1987 (Argoudelis et al.1988) , not in S. albus. Since they do not contain the paulic acid moiety needed for the bioactivity of the molecule, paulomenols do not show antibiotic activity; however, they have industrial use as UV light filters (Wiley 1983) .
Comparative volatile metabolite profiling analyses reveals silencing of metabolites normally produced in the parental strain
Streptomyces albus parental cultures produce a very characteristic odour unlike that of any other Streptomyces (which almost allows identification simply by smelling).
Since changes in odour of some recombinant strains were also detected in r5A solid cultures, a comparative gC-MS analysis to detect volatile metabolites by sporulated surface cultures was carried out. As shown in Fig. 6a , a comparison of volatile profiling between the parental S. albus strain, S. albus/pKC505 and the recombinant S. albus/cosCAT25 shows remarkable differences involving silencing of metabolites normaly produced by the S. albus parental strain. In agreement with the above mentioned UPlC analysis, S. albus/cosCAT14 displayed a similar metabolic profile pattern than S. albus/cosCAT25, whereas the S. albus/cosCAT22 pattern was equivalent to the controls: S. albus parental strain and S. albus/pKC505 (data not shown). Among the metabolites differentially produced in the comparative analysis, four volatile compounds whose biosynthesis was switched off in the recombinant strain (peaks 5-8) were identified using the Whiley database (Table 1 ). All four metabolites are structurally related and belong to a family of flavour compounds known as pyrazines, which have intensive smells and very low odour threshold values (Müller and rappert 2010). Pyrazines are a group of 1, 4 dinitrogen substituted benzenes whose increased demand in recent years owes to their vast applications in the fields of food, agriculture and medicine. They are widely distributed in plants and animals, where they are considered to be alerting signals (Müller and rappert 2010). Among microorganisms, however, pyrazines production is infrequent and only a few bacteria and fungi have been reported to be able to synthesize them (rajini et al. 2011). The predominant pyrazines produced by the parental strain (Fig. 6b)   Fig. 3 and not by the recombinant strain are: 2,3,5,6-tetramethylpyrazine (7); 2,3,5-trimethyl-6-ethyl-pyrazine (8); whereas 2,5-dimethyl-pyrazine (5) and 2,3,5-trimethyl-pyrazine (6) are present at lower concentrations. Tetramethyl-pyrazine displays important biological activities as therapeutical agent and to our knowledge, its production is unprecedented in Streptomyces. Some remaining metabolites present in both, the recombinant and the parental strains, were also identified in S. albus (Table 1) . Most of them are aromatic compounds, mainly sesquiterpene hydrocarbons, being the two major products geosmin (9); and β-patchoulene (10). geosmin, the compound responsible for the "smell of the earth" is widespread among Streptomyces species (Jachymova et al. 2002; Cane and Ikeda 2011) . In contrast, beta-pachoulene, an aromatic compound usually produced by plants and used as fragrance agents in perfume industry, as far as we know has never reported to be produced by bacteria. Another interesting metabolite produced in lower concentrations by S. albus is dihydro-β-agarofuran (11). This compound, previously detected in S. citreus (Pollak and Berger 1996) and normally produced by plants, displays multiple biological activities such as antitumor, anti-VIH, immunossuppresant, multidrug resistance (MDr) reversal and insecticidal activity (gao et al. 2007 ).
Activation of actinorhodin production and silencing of undecylprodigiosins in S. lividans ethyl acetate extracts of r5A solid cultures of the recombinant strain harboring cosCAT32 and the wild type strain were analysed by UPlC after 7 days of growth. As shown in Fig. 7 , comparative metabolite profiling by UPlC mass analysis revealed changes in S. lividans harbouring cosCAT32 in relation to the parental strain and the parental strain harbouring the pHZ1358 control vector (Fig. 7) . Differences were observed when absorbance was measured at 499 nm involving activation of several silent or poorly expressed secondary metabolites and down regulation of others normally expressed in the wild type strain. These values of 392.5 and 394.5). Production of ACT compounds was activated in the recombinant strain, whereas that of reD compounds was strongly reduced. The presence of a silent gene cluster for actinorhodin production in S. lividans has been previously reported (Horinouchi and Beppu 1984) , and also different ways of activating this antibiotic production (romero et al. 1992; Penn et al. 2006) .
In contrast to S. albus, no differences were found when analyzing the volatile metabolite profiling by gC-MS analysis of the S. lividans recombinant strain compared to the control strains (data not shown). The S. lividans wild type volatile spectrum has been previously determined (Jachymova et al. 2002) . The activation/silencing trigger seems to be different in S. lividans from that in S. albus as only CAT32 transformants show induction of Act and reduction of red production.
Discussion
Annotations of Streptomyces genomes revealed that they contain a much greater reservoir of secondary metabolite gene clusters than expected. genome mining is a novel approach for the identification of gene clusters for natural products in sequenced genomes, and the prediction of the coded product by connecting genomes and bioinformatics (Zerikly and Challis 2009; Walsh and Fischbach 2010; Medema et al. 2011; Blin et al. 2013) . Most of these bioinformatically newly discovered cryptic gene clusters are silent or poorly expressed under standard culture laboratory conditions. Interesting speculations for the biological meaning of silencing of antibiotic gene clusters have been proposed in the beta-lactam carbapenem producer Erwinia carotovora (Holden et al. 1998) . Thus, an important challenge is to find out alternative strategies to wake up these otherwise dormant secondary metabolic pathways. We report here the successful activation of silent antibiotic biosynthetic pathways in two well-known Streptomyces strains, S. lividans and S. albus. The thn cluster in multicopy activates actinorhodin production in S. lividans whereas undecylprodigiosin, normally produced by the wild type strain, seems to be down-regulated. It has been previously shown that in S. lividans strains silent clusters, such as the actinorhodin one, can be activated following introduction of heterologous antibiotic biosynthesis clusters (Penn et al. 2006) . The mechanism underlying the activation/silencing phenotype showed here has not been identified so far by subcloning individual regulatory genes (data not shown). Transcriptional organization in this region is very complex (rodríguez et al. 2008, 2010) , in addition we cannot rule out that expression of multiple genes is needed. An alternative hypothesis to explain the phenomenon observed in heterologous hosts is competition for the pool of precursor metabolites among the different pathways. Although, as mentioned, the final product thienamycin was not produced in any of these heterologous hosts, expression of some biosynthetic and regulatory genes of the cluster is likely to occur. In this way, thienamycin precursors (or intermediates) might affect the imbalance of metabolism, thus changing the overall secondary metabolite profiles in the heterologous hosts. Advances in the knowledge of the thienamycin biosynthetic pathway have been recently reviewed (Hamed et al. 2013 ) and the precursors for the thienamycin skeleton proposed as l-glutamic acid, coenzyme A, malonyl-CoA, S-adenosyl methionine (SAM) and pantetheine. Precedents of such a regulatory cross-talk have been reported in other Streptomyces species. In S. coelicolor, cross-regulation of reD and ACT production has been proposed to occur through a mechanism involving competition for the common precursors malonyl-CoA and acetyl-CoA, in a way that a decrease in reD production results in an increase in ACT production (Ou et al. 2009 ). Furthermore, the methyl donor SAM, reported as a regulator for secondary metabolism in Streptomyces, has been shown to enhance streptomycin production in S. griseus by activating adpA transcription (Shin et al. 2006) . Interestingly, all identified compounds involved in the activation/ silencing process reported here are methylated products and the thn cluster contains three SAM-methyltranspherases (núñez et al. 2003) .
Although S. albus J1074 is widely used in many laboratories as heterologous host for producing secondary metabolites from other actinomycetes, our results reveal that it has also the potential to produce multiple secondary metabolites. Dramatic changes in the metabolome of the recombinant strains involving activation of silent secondary metabolite gene clusters, and silencing of others normally active, were revealed by comparative metabolic profiling using UPlC analysis; although many of these metabolites have not been identified. Purification and structure elucidation of four structurally related compounds, actively produced by the recombinant strain, revealed that they correspond to the paulomycins/paulomenols family; only paulomycins show antibiotic activity against gram-positive bacteria, and as mentioned, is used in gonococcal and Chlamydia infections (novak 1988). Although the biosynthetic pathway is unknown, our results suggest that paulomycins and paulomenols are synthesized from the same gene cluster. During time courses of S. albus/cosCAT25 cultures, we have observed that paulomycins are first produced, whereas paulomenols are detected in the cultures later on (data not shown). Paulomycins yields decrease at the same time that paulomenols yields increase, thus indicating that paulomycins biosynthesis occurs prior to paulomenols biosynthesis, and that paulomycins might be intermediates of the paulomenols pathway.
On the other hand, as a result of the gC-MS analysis of volatile substances released by solid cultures, it was observed that the biosynthesis of several flavour metabolites of the pyrazine family was silenced. Among them, one of the major volatile compounds produced by S. albus has been identified as tetramethylpyrazine, also known as ligustrazine since it was originally isolated from the plant Ligusticum wallichi, widely used in traditional chinese medicine. This compound is also the subject of current active research, since it displays multiple biological activities 1 3 with important medical applications. It is used as a therapeutical agent against cardio-and cerebrovascular diseases (Zhang et al. 2003) in lung protection and cystic fibrosis (rajini et al. 2011) . Only two bacterial genera are reported to produce tetramethylpirazine: a mutant of Corynebacterium glutamicum obtained with nTg (Demain et al. 1967) and Bacillus species (Cane and Ikeda 2011). To the best of our knowledge this is the first report of tetramethylpyrazine production by Streptomyces. Another volatile compound of medical interest produced by S. albus parental strain is dihydro-β-agarofuran, which displays multiple and diverse biological activities such as antitumor, anti-VIH, immunossuppresant, MDr reversal and insecticidal activity (gao et al. 2007 ). In addition, S. albus also produces great amounts of β-patchoulene, an aromatic compound of interest as fragrance in perfume industry, traditionally obtained from the plant Pogostemon cablin (patchouli), which as far as we know has never been reported to be produced by prokaryotes.
These findings might open the field to use Streptomyces as an alternative model for industrial production of compounds of pharmacological and medical interests, and also for the perfume industry, usually produced by plants. All together, the present study revealed that the biosynthetic potential of S. albus has been greatly underestimated. S. albus has the ability to produce multiple secondary metabolites, including compounds of pharmaceutical and industrial interest. Discovery of some of these metabolites, together with bioinformatic mining on its recently sequenced genome (Zaburannyi et al. 2014) , might help in linking gene clusters to produced metabolites, specially when the molecules structure can not be easily predicted from in silico analysis.
An interesting point is that molecules, whose production was activated in S. albus and S. lividans hosts, are structurally unrelated and so are they to the β-lactam carbapenem thienamycin, of the native producer S. cattleya. It was previously reported that in streptomycetes, there is an extensive 'cross-talk' between pathway-specific regulators in different biosynthetic pathways (Huang et al. 2005) . The possibility of a mechanism which functions across different producers represents a promising approach to the discovery of cryptic secondary metabolites in Streptomyces. Anyway, further investigations need to be done to identify the mechanism underlying this inter-species activation process. Understanding the nature of this phenomenon might facilitate the discovery of cryptic natural products, by awakening some of the great number of dormant gene clusters of the Streptomyces genomes, bringing to light these "hidden treasures".
